Imtiaz A Samjoo

22PUBLICATIONS
43CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicinePredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 06, 2026
Methodological pitfalls in indirect treatment comparisons: insights from a recent systematic review and analysis for C3 glomerulopathy.

|Jul 28, 2026
A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.

|Mar 28, 2026
Response to "Treatment Outcomes with Lanadelumab Every Two Weeks and Garadacimab Are Very Similar in Patients with Hereditary Angioedema".

Imtiaz A Samjoo

|Aug 12, 2025
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.

Jianming He, Karen Chiang, Xiwu Lin

|Jul 10, 2025
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.

Sarah Walsh, Anja Haltner, Meaghan Bartlett

|May 28, 2025
Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema.

Sarah Walsh, Meaghan Bartlett, Elizabeth M Salvo-Halloran

Pageof 4

Frequent Collaborators

9 joint publications

Anja Haltner

8 joint publications

Chris Cameron

6 joint publications

Evelyn Worthington

5 joint publications

Christopher Drudge